News | June 30, 2025
Biocon Biologics expands insulin access in Malaysia
Over 100 million cartridges of rh-insulin supplied to Malaysian health ministry; 345,000+ patients served
Over 100 million cartridges of rh-insulin supplied to Malaysian health ministry; 345,000+ patients served
Clarity in regulatory frameworks and pathways help in preventing delays in accessing quality-assured, affordable medicines
10+ emerging markets, Japan & ANZ transition in final phase
Takes over the commercialization of Biosimilars Business from Viatris in 70+ countries
Biocon Biologics’ Insugen formulations will be available to patients at all Ministry of Health hospitals, district health offices and health clinics
Subscribe To Our Newsletter & Stay Updated
